Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs April 29, 2025
Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines February 14, 2025
